Cargando…

Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic

INTRODUCTION: Depression and anxiety are common. Rates are significantly higher in cystic fibrosis (CF), and impact health outcomes. Screening is recommended, but is difficult to implement/sustain annually in a busy CF centre. The aim was to develop an acceptable model for depression and anxiety scr...

Descripción completa

Detalles Bibliográficos
Autores principales: Goetz, Danielle Marie, Frederick, Carla, Savant, Adrienne, Cogswell, Alex, Fries, Lynne, Roach, Christine, Shea, Nicole, Borowitz, Drucy, Smith, Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098908/
https://www.ncbi.nlm.nih.gov/pubmed/33941540
http://dx.doi.org/10.1136/bmjoq-2020-001333
_version_ 1783688499498582016
author Goetz, Danielle Marie
Frederick, Carla
Savant, Adrienne
Cogswell, Alex
Fries, Lynne
Roach, Christine
Shea, Nicole
Borowitz, Drucy
Smith, Beth
author_facet Goetz, Danielle Marie
Frederick, Carla
Savant, Adrienne
Cogswell, Alex
Fries, Lynne
Roach, Christine
Shea, Nicole
Borowitz, Drucy
Smith, Beth
author_sort Goetz, Danielle Marie
collection PubMed
description INTRODUCTION: Depression and anxiety are common. Rates are significantly higher in cystic fibrosis (CF), and impact health outcomes. Screening is recommended, but is difficult to implement/sustain annually in a busy CF centre. The aim was to develop an acceptable model for depression and anxiety screening in adolescents/adults with CF and their caregivers that could be sustained and shared. METHODS: Quality improvement methodology with plan-do-study-act cycles, flow diagrams, review of data monthly with our designated ‘Mental Health Team’ and caregiver satisfaction surveys, were used to begin screening in clinics and to improve the process. We then piloted our process at a larger paediatric CF centre. RESULTS: Prior to 2013, screening was not performed at our CF centre. After the first quarter of depression screening, 88% of adolescents and 69% of adults with CF were screened. The process was refined. By the second year, 99% of patients were screened. Anxiety screening began in year three; 97%–99% of patients were screened for both anxiety and depression in years 3–5. Annual caregiver screening rates were >95%. Screening was changed from Patient Health Questionnaire-2 (PHQ-2) to PHQ-9 due to better sensitivity in caregivers, and expanded to patients. Anxiety screening began in year 3 with the Generalised Anxiety Disorder-7 questionnaire. Patients and caregivers reported acceptance of screening. At the larger paediatric centre used as a pilot, 89.6% of patients were screened in year 1. Feedback included recommendations to improve tracking/follow-up of positive screens. CONCLUSIONS: Development and implementation of a stepwise process for depression and anxiety screening was successful in a paediatric/adult CF clinic, due to constant re-evaluation by an engaged team with feedback from patients via survey. A systematic approach at a busy CF centre can serve as a model to implement screening in a clinic.
format Online
Article
Text
id pubmed-8098908
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-80989082021-05-18 Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic Goetz, Danielle Marie Frederick, Carla Savant, Adrienne Cogswell, Alex Fries, Lynne Roach, Christine Shea, Nicole Borowitz, Drucy Smith, Beth BMJ Open Qual Quality Improvement Report INTRODUCTION: Depression and anxiety are common. Rates are significantly higher in cystic fibrosis (CF), and impact health outcomes. Screening is recommended, but is difficult to implement/sustain annually in a busy CF centre. The aim was to develop an acceptable model for depression and anxiety screening in adolescents/adults with CF and their caregivers that could be sustained and shared. METHODS: Quality improvement methodology with plan-do-study-act cycles, flow diagrams, review of data monthly with our designated ‘Mental Health Team’ and caregiver satisfaction surveys, were used to begin screening in clinics and to improve the process. We then piloted our process at a larger paediatric CF centre. RESULTS: Prior to 2013, screening was not performed at our CF centre. After the first quarter of depression screening, 88% of adolescents and 69% of adults with CF were screened. The process was refined. By the second year, 99% of patients were screened. Anxiety screening began in year three; 97%–99% of patients were screened for both anxiety and depression in years 3–5. Annual caregiver screening rates were >95%. Screening was changed from Patient Health Questionnaire-2 (PHQ-2) to PHQ-9 due to better sensitivity in caregivers, and expanded to patients. Anxiety screening began in year 3 with the Generalised Anxiety Disorder-7 questionnaire. Patients and caregivers reported acceptance of screening. At the larger paediatric centre used as a pilot, 89.6% of patients were screened in year 1. Feedback included recommendations to improve tracking/follow-up of positive screens. CONCLUSIONS: Development and implementation of a stepwise process for depression and anxiety screening was successful in a paediatric/adult CF clinic, due to constant re-evaluation by an engaged team with feedback from patients via survey. A systematic approach at a busy CF centre can serve as a model to implement screening in a clinic. BMJ Publishing Group 2021-05-03 /pmc/articles/PMC8098908/ /pubmed/33941540 http://dx.doi.org/10.1136/bmjoq-2020-001333 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Quality Improvement Report
Goetz, Danielle Marie
Frederick, Carla
Savant, Adrienne
Cogswell, Alex
Fries, Lynne
Roach, Christine
Shea, Nicole
Borowitz, Drucy
Smith, Beth
Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title_full Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title_fullStr Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title_full_unstemmed Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title_short Systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
title_sort systematic depression and anxiety screening for patients and caregivers: implementation and process improvement in a cystic fibrosis clinic
topic Quality Improvement Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8098908/
https://www.ncbi.nlm.nih.gov/pubmed/33941540
http://dx.doi.org/10.1136/bmjoq-2020-001333
work_keys_str_mv AT goetzdaniellemarie systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT frederickcarla systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT savantadrienne systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT cogswellalex systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT frieslynne systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT roachchristine systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT sheanicole systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT borowitzdrucy systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic
AT smithbeth systematicdepressionandanxietyscreeningforpatientsandcaregiversimplementationandprocessimprovementinacysticfibrosisclinic